← Back to Search

Behavioral Intervention

PTSD Treatment for Veterans with Mental Illness

N/A

Recruiting

Led By Mary K Howell, PhD

Research Sponsored by VA Office of Research and Development

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up at study completion, approximately 4 years

Awards & highlights

Study Summary

This trial aims to develop and test treatments for PTSD in Veterans with serious mental illness (SMI) to improve their mental health. BIPOC disparities in prevalence and treatment use will be addressed.

Who is the study for?

This trial is for Veterans with serious mental illness (SMI) such as psychotic spectrum or bipolar disorders, who are also diagnosed with PTSD. They must be enrolled in outpatient mental health services and have regular phone access. Those already in trauma-focused therapy or with moderate-to-severe substance use issues cannot participate.Check my eligibility

What is being tested?

The study tests the feasibility of Written Exposure Therapy (WET), a treatment for PTSD, in Veterans with SMI. It also evaluates culturally responsive assessment methods to see if they're suitable and acceptable for this group before considering a larger trial.See study design

What are the potential side effects?

While specific side effects are not listed, psychological therapies like WET may sometimes cause temporary increases in distress due to recalling traumatic events during treatment.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ at study completion, approximately 4 years

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~at study completion, approximately 4 years

This trial's timeline: 3 weeks for screening, Varies for treatment, and at study completion, approximately 4 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Client Satisfaction Questionnaire (CSQ-8)

Mean number of sessions attended

Number of participants eligible divided by Individuals approached for recruitment

+2 more

Secondary outcome measures

Clinician-administered PTSD Scale for DSM-5 (CAPS-5) - Past Month Version

World Health Organization Disability Assessment Schedule 2.0 (WHODAS 2.0)

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Written Exposure Therapy (WET)Experimental Treatment1 Intervention

5 individual therapy sessions of WET via video telehealth

Group II: PTSD Education ControlActive Control1 Intervention

5 individual sessions of PTSD psychoeducation via video telehealth

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Written Exposure Therapy

2021

Completed Phase 2

~370

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

VA Office of Research and DevelopmentLead Sponsor

1,611 Previous Clinical Trials

3,305,236 Total Patients Enrolled

Mary K Howell, PhDPrincipal InvestigatorBaltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD

Media Library

Written Exposure Therapy (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05674617 — N/A

Post-Traumatic Stress Disorder Research Study Groups: Written Exposure Therapy (WET), PTSD Education Control

Post-Traumatic Stress Disorder Clinical Trial 2023: Written Exposure Therapy Highlights & Side Effects. Trial Name: NCT05674617 — N/A

Written Exposure Therapy (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05674617 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any vacancies available for participants in this trial?

"According to data hosted on clinicaltrials.gov, this experiment has ceased its recruitment process as of the most recent update on May 1st 2023. Nevertheless, there are over seven hundred other trials that still require patients at present time."

Answered by AI